Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin ten Haaf

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
JAMA Network Open|March 2, 2019
Development and Validation of a Multivariable Lung Cancer Risk Prediction Model That Includes Low-Dose Computed Tomography Screening Results: A Secondary Analysis of Data From the National Lung Screening TrialMartin C Tammemägi, Kevin Ten Haaf, Iakovos Toumazis, et al.
JAMA Network Open|July 24, 2025
Computed Tomographic Screening Intervals for Patients at Moderate Risk of Lung CancerKoen de Nijs, Harry J de Koning, Pianpian Cao, et al.
Eclinicalmedicine|September 11, 2025
Influence of changing patterns in lung cancer treatment and survival on the cost-effectiveness of CT screening: a modeling studyKoen de Nijs, Kevin Ten Haaf, Dana Moldovanu, et al.
Journal of the National Cancer Institute|January 23, 2026
Performance of smoking duration-based lung cancer screening eligibility criteria: a comparative modeling studyPianpian Cao, Koen De Nijs, Justin Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|June 3, 2018
Cost-effectiveness of low-dose CT screening for lung cancer in a European country with high prevalence of smoking-A modelling studyYuki Tomonaga, Kevin Ten Haaf, Thomas Frauenfelder, et al.
Lung Cancer (Amsterdam, Netherlands)|August 8, 2025
Impact of recruitment method on informed decision-making in lung cancer screening in the 4-IN-THE-LUNG-RUN trialJuul Hubert, Dana Moldovanu, Isabelle van den Bosch, et al.
Journal of the National Cancer Institute|February 11, 2020
Disparities of National Lung Cancer Screening Guidelines in the US PopulationSummer S Han, Eric Chow, Kevin Ten Haaf, et al.
Plos Medicine|February 8, 2017
Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, CanadaKevin Ten Haaf, Martin C Tammemägi, Susan J Bondy, et al.
Plos Medicine|September 25, 2020
Correction: Risk prediction models for selection of lung cancer screening candidates: A retrospective validation studyKevin Ten Haaf, Jihyoun Jeon, Martin C Tammemägi, et al.
Plos Medicine|April 5, 2017
Risk prediction models for selection of lung cancer screening candidates: A retrospective validation studyKevin Ten Haaf, Jihyoun Jeon, Martin C Tammemägi, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
JAMA Network Open|March 2, 2019
Development and Validation of a Multivariable Lung Cancer Risk Prediction Model That Includes Low-Dose Computed Tomography Screening Results: A Secondary Analysis of Data From the National Lung Screening TrialMartin C Tammemägi, Kevin Ten Haaf, Iakovos Toumazis, et al.
JAMA Network Open|July 24, 2025
Computed Tomographic Screening Intervals for Patients at Moderate Risk of Lung CancerKoen de Nijs, Harry J de Koning, Pianpian Cao, et al.
Eclinicalmedicine|September 11, 2025
Influence of changing patterns in lung cancer treatment and survival on the cost-effectiveness of CT screening: a modeling studyKoen de Nijs, Kevin Ten Haaf, Dana Moldovanu, et al.
Journal of the National Cancer Institute|January 23, 2026
Performance of smoking duration-based lung cancer screening eligibility criteria: a comparative modeling studyPianpian Cao, Koen De Nijs, Justin Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|June 3, 2018
Cost-effectiveness of low-dose CT screening for lung cancer in a European country with high prevalence of smoking-A modelling studyYuki Tomonaga, Kevin Ten Haaf, Thomas Frauenfelder, et al.
Lung Cancer (Amsterdam, Netherlands)|August 8, 2025
Impact of recruitment method on informed decision-making in lung cancer screening in the 4-IN-THE-LUNG-RUN trialJuul Hubert, Dana Moldovanu, Isabelle van den Bosch, et al.
Journal of the National Cancer Institute|February 11, 2020
Disparities of National Lung Cancer Screening Guidelines in the US PopulationSummer S Han, Eric Chow, Kevin Ten Haaf, et al.
Plos Medicine|February 8, 2017
Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, CanadaKevin Ten Haaf, Martin C Tammemägi, Susan J Bondy, et al.
Plos Medicine|September 25, 2020
Correction: Risk prediction models for selection of lung cancer screening candidates: A retrospective validation studyKevin Ten Haaf, Jihyoun Jeon, Martin C Tammemägi, et al.
Plos Medicine|April 5, 2017
Risk prediction models for selection of lung cancer screening candidates: A retrospective validation studyKevin Ten Haaf, Jihyoun Jeon, Martin C Tammemägi, et al.
Pageof 6